Golden Recursion Inc. logoGolden Recursion Inc. logo
Advanced Search

Aviv Regev

Bioinformatician at the Broad Institute of Harvard and MIT, founder of Celsius Therapeutics and co-chair of the organizing committee for the Human Cell Atlas.

Help us improve this page by adding information.
Visit our Writing Guide or this topic page for additional help.

Timeline

July 11, 1971
Aviv Regev was born.

Patents

Further Resources

Title
Author
Link
Type
Date

News

Title
Author
Date
Publisher
Description
Giles Turner and Tom Giles | Bloomberg
August 4, 2021
@bsindia
The Japanese conglomerate is now one of Roches largest investors, according to data compiled by Bloomberg.
Alex Keown
May 11, 2020
BioSpace
Pharma veteran Michael Varney, Genentech's head of Research and Development, will retire from the company at the end of July after spending 15 years with the company.
Nick Paul
May 11, 2020
FierceBiotech
Roche has named Aviv Regev as the new head of Genentech research and early development (gRED). Regev, who currently works at the Broad Institute, will take over as head of gRED when Michael Varney retires at the end of July.
Reuters Editorial
May 11, 2020
U.S.
Roche said Monday it has hired a Massachusetts Institute of Technology (MIT) professor as the new head of the Swiss drugmaker's U.S. research arm that was responsible for some of the company's best-selling medicines of the last few decades.
By MALCOLM RITTER
March 4, 2019
AP NEWS
NEW YORK (AP) -- Did you hear what happened when Bill Gates walked into a bar? Everybody there immediately became millionaires -- on average. That joke about a very rich man is an old one...
Golden logo
By using this site, you agree to our Terms & Conditions.